0001493152-23-027579.txt : 20230810
0001493152-23-027579.hdr.sgml : 20230810
20230810163035
ACCESSION NUMBER: 0001493152-23-027579
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230808
FILED AS OF DATE: 20230810
DATE AS OF CHANGE: 20230810
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KOSKI ROBERT C
CENTRAL INDEX KEY: 0001234880
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32188
FILM NUMBER: 231160044
MAIL ADDRESS:
STREET 1: 1500 W UNIVERSITY PARKWAY
CITY: SARASOTA
STATE: FL
ZIP: 34243
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ORAGENICS INC
CENTRAL INDEX KEY: 0001174940
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 593410522
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4902 EISENHOWER BLVD
STREET 2: SUITE 125
CITY: TAMPA
STATE: FL
ZIP: 33634
BUSINESS PHONE: 8132867900
MAIL ADDRESS:
STREET 1: 4902 EISENHOWER BLVD
STREET 2: SUITE 125
CITY: TAMPA
STATE: FL
ZIP: 33634
4
1
ownership.xml
X0508
4
2023-08-08
0
0001174940
ORAGENICS INC
OGEN
0001234880
KOSKI ROBERT C
4902 EISENHOWER BOULEVARD
TAMPA
FL
33634
1
0
0
0
0
Common Stock
2023-08-08
4
A
0
25000
0
A
25689
D
Common Stock
18367
I
See Footnote
Represents an award of restricted stock pursuant to the Company's non-employee director compensation program under the Company's 2021 Equity Incentive Plan with 20,000 shares vesting immediately and 5,000 shares vesting in six (6) months.
Reflects adjustments made in connection with the 1-for-60 reverse stock split of the Issuer's common stock which became effective on January 23, 2023.
Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.
/s/ Mark A. Catchur, as Attorney-in-Fact for Robert C. Koski
2023-08-10